cardiovascular disease risk: The NHANES I Follow-up
Study cohort. The Lancet, 371(9616), 923–931.
https://doi.org/10.1016/S0140-6736(08)60418-3
Golovaty, I., Sharma, M., Van Heerden, A., van Rooyen,
H., Baeten, J. M., Celum, C., & Barnabas, R. V. (2018).
Cost of Integrating Noncommunicable Disease
Screening Into Home-Based HIV Testing and
Counseling in South Africa: JAIDS Journal of Acquired
Immune Deficiency Syndromes, 78(5), 522–526.
https://doi.org/10.1097/QAI.0000000000001713
Gopalan, H. S., & Misra, A. (2020). COVID-19 pandemic
and challenges for socio-economic issues, healthcare
and National Health Programs in India. Diabetes &
Metabolic Syndrome: Clinical Research & Reviews,
14(5), 757–759.
https://doi.org/10.1016/j.dsx.2020.05.041
Kontis, V., Mathers, C. D., Rehm, J., Stevens, G. A., Shield,
K. D., Bonita, R., Riley, L. M., Poznyak, V.,
Beaglehole, R., & Ezzati, M. (2014). Contribution of
six risk factors to achieving the 25×25 non-
communicable disease mortality reduction target: A
modelling study. The Lancet, 384(9941), 427–437.
https://doi.org/10.1016/S0140-6736(14)60616-4
Krishnan, A., Gupta, V., Ritvik, Nongkynrih, B., & Thakur,
J. (2011). How to Effectively Monitor and Evaluate
NCD Programmes in India. Indian Journal of
Community Medicine : Official Publication of Indian
Association of Preventive & Social Medicine,
36(Suppl1), S57–S62. https://doi.org/10.4103/0970-
0218.94710
Kroll, M., Phalkey, R. K., & Kraas, F. (2015). Challenges
to the surveillance of non-communicable diseases – a
review of selected approaches. BMC Public Health,
15(1), 1243. https://doi.org/10.1186/s12889-015-2570-
z
Malcolm, S., Cadet, J., Crompton, L., & DeGennaro, V.
(2019). A model for point of care testing for non-
communicable disease diagnosis in resource-limited
countries. Global Health, Epidemiology and Genomics,
4. https://doi.org/10.1017/gheg.2019.6
Mathur, P., & Rangamani, S. (2020). COVID-19 and
noncommunicable diseases: Identifying research
priorities to strengthen public health response.
International Journal of Noncommunicable Diseases,
5(2), 76. https://doi.org/10.4103/jncd.jncd_33_20
Menon, J., Joseph, J., Thachil, A., Attacheril, T. V., &
Banerjee, A. (2014). Surveillance of
Noncommunicable Diseases by Community Health
Workers in Kerala: The Epidemiology of
Noncommunicable Diseases in Rural Areas (ENDIRA)
Study. Global Heart, 9(4), 409–417.
https://doi.org/10.1016/j.gheart.2014.07.003
Ministry of Health and Family Welfare, Government of
India. (2017, July 13). Cardiovascular, Respiratory,
and Related Disorders: Key Messages on Essential
Interventions to Address its Burden in Low-and Middle-
Income Countries | DCP3
. National Programme for
Prevention and Control of Cancer, Diabetes,
Cardiovascular Diseases and Stroke (NPCDCS).
http://dcp-3.org/chapter/2306/overview
NCDs | STEPS Manual. (2002). WHO; World Health
Organization. Retrieved April 10, 2020, from
http://www.who.int/ncds/surveillance/steps/manual/en
/
OMS. (2011). Global status report on noncommunicable
diseases 2010. OMS (Organizacion Mundial de la
Salud).
Pandya Ankur, Weinstein Milton C., Salomon Joshua A.,
Cutler David, & Gaziano Thomas A. (2014). Who
Needs Laboratories and Who Needs Statins?
Circulation: Cardiovascular Quality and Outcomes,
7(1), 25–32.
https://doi.org/10.1161/CIRCOUTCOMES.113.00039
7
Prakash Upadhyay, R. (2012). An overview of the burden
of non- communicable diseases in India. Iranian
Journal of Public Health, 41(3), 1–8. Scopus.
Shah, B., & Mathur, P. (2010). Surveillance of
cardiovascular disease risk factors in India: The need &
scope. The Indian Journal of Medical Research, 132(5),
634–642. https://doi.org/10.4103/0971-5916.73420
Subramanian, S., Gakunga, R., Kibachio, J., Gathecha, G.,
Edwards, P., Ogola, E., Yonga, G., Busakhala, N.,
Munyoro, E., Chakaya, J., Ngugi, N., Mwangi, N., Von
Rege, D., Wangari, L.-M., Wata, D., Makori, R.,
Mwangi, J., Mwanda, W., & on behalf of the East
African Economics and Implementation Group
(EAEIG). (2018). Cost and affordability of non-
communicable disease screening, diagnosis and
treatment in Kenya: Patient payments in the private and
public sectors. PLOS ONE, 13(1), e0190113.
https://doi.org/10.1371/journal.pone.0190113
Webber, L., Divajeva, D., Marsh, T., McPherson, K.,
Brown, M., Galea, G., & Breda, J. (2014). The future
burden of obesity-related diseases in the 53 WHO
European-Region countries and the impact of effective
interventions: A modelling study. BMJ Open, 4(7),
e004787–e004787. https://doi.org/10.1136/bmjopen-
2014-004787
World Health Organization. (2010). Package of essential
noncommunicable (PEN) disease interventions for
primary health care in low-resource settings.
http://www.who.int/nmh/publications/essential.